MD247C2 - Procedeu de obţinere a formei hidratate cristaline a sării de sodiu a acidului 3-acetoximetil-7-[2-(2-amino-4-tiazolil)-2-metoxiiminoacetamido] -cef-3-em-4-carbonic, a sin-izomerului - Google Patents

Procedeu de obţinere a formei hidratate cristaline a sării de sodiu a acidului 3-acetoximetil-7-[2-(2-amino-4-tiazolil)-2-metoxiiminoacetamido] -cef-3-em-4-carbonic, a sin-izomerului

Info

Publication number
MD247C2
MD247C2 MD94-0275A MD940275A MD247C2 MD 247 C2 MD247 C2 MD 247C2 MD 940275 A MD940275 A MD 940275A MD 247 C2 MD247 C2 MD 247C2
Authority
MD
Moldova
Prior art keywords
cef
amino
crystalline form
carbonic acid
natrium
Prior art date
Application number
MD94-0275A
Other languages
English (en)
Russian (ru)
Other versions
MD247B1 (ro
Inventor
Gaston Amiard
Dieter Bormann
Walter Duerckheimer
Jean Jolly
Original Assignee
Roussel Uclaf, Societe Anonyme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9194564&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MD247(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roussel Uclaf, Societe Anonyme filed Critical Roussel Uclaf, Societe Anonyme
Publication of MD247B1 publication Critical patent/MD247B1/ro
Publication of MD247C2 publication Critical patent/MD247C2/ro

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Invenţia se referă la procedeul de obţinere a antibioticelor din grupa cefalosporinelor, şi anume a formei hidratate cristaline a sării de sodiu a acidului 3-acetoximetil-7-[2-(2-amino-4-tiazolil)-2-metoxiiminoacetamido]-cef-3-em-4-carbonic, a sin-izomerului cu formula 1:Scopul invenţiei constă în prepararea unui nou antibiotic cefalosporinic într-o nouă formă cristalină, cu o stabilitate sporită.Procedeul prevede tratarea acidului 3-acetoximetil-7-[2-(2-amino-4-tiazolil)-2-metoxiiminoacetamido]-cef-3-em-4-carbonic, a sin-izomerului sau a hidratului lui, a solvatului etanolic şi celui formiatic sau a amestecului hidratului şi solvatului etanolic sau formiatic cu sare de sodiu, selectată din grupa ce include acetatul, dietilacetatul şi 2-etilhexanoatul de sodiu în mediu de solvent, selectat din grupa ce include metanol, apos, etanol apos, acetonă apoasă şi izopropanol apos. Produsul cu destinaţie specială se separă prin cristalizare, în caz de necesitate, adăugându-se un solvent, selectat din grupa ce include etanol, etanol ce conţine 0,5-10% de greutate de apă, acetonă şi izopropanol.
MD94-0275A 1977-08-17 1994-09-08 Procedeu de obţinere a formei hidratate cristaline a sării de sodiu a acidului 3-acetoximetil-7-[2-(2-amino-4-tiazolil)-2-metoxiiminoacetamido] -cef-3-em-4-carbonic, a sin-izomerului MD247C2 (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7725142A FR2400519A1 (fr) 1977-08-17 1977-08-17 Forme cristalline du sel de sodium d'un derive oximine de l'acide 7-amino-thiazolyl acetamido cephalosporanique, son procede de preparation et son application comme medicament
SU782645701A SU799666A3 (ru) 1977-08-17 1978-08-09 Способ получени гидратированной крис-ТАлличЕСКОй фОРМы НАТРиЕВОй СОли 3-АцЕТОКСи-МЕТил-7 2-(2-АМиНО-4-ТиАзОлил)-2-МЕТОКСи-иМиНОАцЕТАМидО цЕф-3-EM-4-КАРбОНОВОй КиС-лОТы,СиН-изОМЕРА

Publications (2)

Publication Number Publication Date
MD247B1 MD247B1 (ro) 1995-07-31
MD247C2 true MD247C2 (ro) 1995-12-31

Family

ID=9194564

Family Applications (2)

Application Number Title Priority Date Filing Date
MD94-0275A MD247C2 (ro) 1977-08-17 1994-09-08 Procedeu de obţinere a formei hidratate cristaline a sării de sodiu a acidului 3-acetoximetil-7-[2-(2-amino-4-tiazolil)-2-metoxiiminoacetamido] -cef-3-em-4-carbonic, a sin-izomerului
MD94-0267A MD225C2 (ro) 1977-08-17 1994-09-08 Procedeu de obţinere a formei hidratate cristaline a sării de sodiu a acidului 3-acetoximetil-7-12-(2-amino-4-tiazolil)-2-metoxiiminoacetamido-cef-3-em-4-carbonic, sin-izomerului

Family Applications After (1)

Application Number Title Priority Date Filing Date
MD94-0267A MD225C2 (ro) 1977-08-17 1994-09-08 Procedeu de obţinere a formei hidratate cristaline a sării de sodiu a acidului 3-acetoximetil-7-12-(2-amino-4-tiazolil)-2-metoxiiminoacetamido-cef-3-em-4-carbonic, sin-izomerului

Country Status (34)

Country Link
US (1) US4224371A (ro)
EP (1) EP0001024B1 (ro)
JP (1) JPS5441890A (ro)
AT (2) AT366049B (ro)
AU (1) AU520898B2 (ro)
BG (2) BG33887A3 (ro)
CA (1) CA1121343A (ro)
CS (2) CS207646B2 (ro)
DD (1) DD137588A5 (ro)
DE (1) DE2860358D1 (ro)
DK (2) DK152213C (ro)
EG (1) EG13520A (ro)
ES (1) ES472381A1 (ro)
FI (1) FI65433C (ro)
FR (1) FR2400519A1 (ro)
GE (2) GEP19960475B (ro)
GR (1) GR73661B (ro)
HR (1) HRP931395B1 (ro)
HU (1) HU181497B (ro)
IE (1) IE47230B1 (ro)
IL (1) IL55186A (ro)
IT (1) IT1107961B (ro)
MD (2) MD247C2 (ro)
MX (2) MX155976A (ro)
NO (1) NO156168C (ro)
NZ (1) NZ188163A (ro)
OA (1) OA06016A (ro)
PL (1) PL126619B1 (ro)
PT (1) PT68431A (ro)
RO (1) RO79999A (ro)
SI (1) SI7811917A8 (ro)
SU (2) SU799666A3 (ro)
YU (1) YU42166B (ro)
ZA (1) ZA784187B (ro)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60120886A (ja) * 1983-12-02 1985-06-28 Takeda Chem Ind Ltd セフェムカルボン酸のナトリウム塩の結晶
JPS60142987A (ja) * 1983-12-29 1985-07-29 Mochida Pharmaceut Co Ltd セフアロスポリン誘導体
DE150507T1 (de) * 1983-12-29 1987-02-26 Mochida Pharmaceutical Co., Ltd., Tokio/Tokyo Cephalosporinverbindungen, verfahren zu ihrer herstellung und pharmazeutishe praeparate.
US4840945A (en) * 1985-04-01 1989-06-20 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
JPH0749432B2 (ja) * 1985-08-12 1995-05-31 ジ・アップジョン・カンパニ− セファロスポリンハロゲン化水素酸塩のアルカリ金属塩への変換
US4880798A (en) * 1986-11-25 1989-11-14 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
JPS63132893A (ja) * 1986-11-25 1988-06-04 Mochida Pharmaceut Co Ltd 新規セフアロスポリン誘導体、その製法およびそれらを有効成分とする抗菌剤
RU2021274C1 (ru) 1991-05-17 1994-10-15 Польска Акадэмия Наук Институт Хэмии Органичнэй Способ получения аминотиазолильных производных цефалоспорина
US5318781A (en) * 1993-04-06 1994-06-07 Hoffmann-La Roche Inc. Absorption enhancement of antibiotics
US5574154A (en) * 1994-09-29 1996-11-12 Alnejma Bulk Pharmaceutical Co. A.B.P.C. Process for the preparation of cephalosporanic compounds
GB9423459D0 (en) * 1994-11-21 1995-01-11 Biochemie Gmbh Silylation process
AT402928B (de) * 1994-12-23 1997-09-25 Biochemie Gmbh Neues verfahren zur herstellung von cefotaxim
AU690482B2 (en) * 1996-03-18 1998-04-23 Ranbaxy Laboratories Limited Process for producing cephalosporin antibiotics
GB9717629D0 (en) * 1997-08-21 1997-10-22 Johnson Matthey Plc Removal of residual organic solvents
WO2001092254A1 (en) * 2000-05-30 2001-12-06 Fujisawa Pharmaceutical Co., Ltd. Method for replacing organic solvents contained in clathrate crystals
WO2004063203A1 (en) * 2003-01-10 2004-07-29 Orchid Chemicals & Pharmaceuticals Ltd Process for the preparation of cefotaxime sodium
CN100361995C (zh) * 2004-10-27 2008-01-16 山东瑞阳制药有限公司 注射级无菌头孢噻肟钠的一步法制备工艺

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3970651A (en) * 1974-01-07 1976-07-20 Bristol-Myers Company Crystalline cephalosporin derivative
US3985747A (en) * 1974-05-24 1976-10-12 Bristol-Myers Company Crystalline sesquihydrate of 7-[D-α-amino-α-(p-hydroxyphenyl)acetamido]-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
US4006138A (en) * 1975-04-11 1977-02-01 Eli Lilly And Company Crystalline form of sodium O-formylcefamandole
SE440655B (sv) * 1976-01-23 1985-08-12 Roussel Uclaf Sett att framstella nya oximderivat av 7-amino-tiazolyl-acetamido-cefalosporansyra
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Cererea nr. 2439818/23-04, SU, Int. cl. C 07 D 501/60, 1976 *

Also Published As

Publication number Publication date
DK152213B (da) 1988-02-08
DE2860358D1 (en) 1981-03-12
AT366050B (de) 1982-03-10
AU3896578A (en) 1980-02-21
SI7811917A8 (en) 1997-12-31
FI782494A7 (fi) 1979-02-18
IL55186A0 (en) 1978-09-29
YU191778A (en) 1983-02-28
JPS6145626B2 (ro) 1986-10-08
NO782782L (no) 1979-02-20
BG33887A3 (bg) 1983-05-16
OA06016A (fr) 1981-06-30
HRP931395B1 (en) 1996-04-30
GEP19960476B (en) 1996-07-22
ZA784187B (en) 1979-09-26
CA1121343A (fr) 1982-04-06
PL209080A1 (pl) 1979-06-04
IT7850648A0 (it) 1978-08-08
DK159786D0 (da) 1986-04-09
MX155976A (es) 1988-06-06
NO156168B (no) 1987-04-27
EG13520A (en) 1982-03-31
EP0001024A1 (fr) 1979-03-07
FI65433B (fi) 1984-01-31
GR73661B (ro) 1984-03-28
ATA52280A (de) 1981-07-15
RO79999A (ro) 1982-10-11
DK163514B (da) 1992-03-09
HU181497B (en) 1983-07-28
SU852175A3 (ru) 1981-07-30
FR2400519A1 (fr) 1979-03-16
ATA563578A (de) 1981-07-15
MD247B1 (ro) 1995-07-31
MX5448E (es) 1983-08-09
DK163514C (da) 1992-07-27
DK152213C (da) 1988-07-11
PL126619B1 (en) 1983-08-31
IT1107961B (it) 1985-12-02
SU799666A3 (ru) 1981-01-23
IE47230B1 (en) 1984-01-25
ES472381A1 (es) 1979-03-16
EP0001024B1 (fr) 1981-01-21
PT68431A (fr) 1978-09-01
DD137588A5 (de) 1979-09-12
MD225B1 (ro) 1995-06-30
DK361078A (da) 1979-02-18
AT366049B (de) 1982-03-10
MD225C2 (ro) 1995-12-31
CS207647B2 (en) 1981-08-31
JPS5441890A (en) 1979-04-03
FI65433C (fi) 1984-05-10
US4224371A (en) 1980-09-23
YU42166B (en) 1988-06-30
DK159786A (da) 1986-04-09
NZ188163A (en) 1981-10-19
AU520898B2 (en) 1982-03-04
BG33888A3 (bg) 1983-05-16
GEP19960475B (en) 1996-07-22
FR2400519B1 (ro) 1980-05-16
IL55186A (en) 1981-07-31
NO156168C (no) 1987-08-19
CS207646B2 (en) 1981-08-31
IE781669L (en) 1979-02-17

Similar Documents

Publication Publication Date Title
MD247C2 (ro) Procedeu de obţinere a formei hidratate cristaline a sării de sodiu a acidului 3-acetoximetil-7-[2-(2-amino-4-tiazolil)-2-metoxiiminoacetamido] -cef-3-em-4-carbonic, a sin-izomerului
ES8202546A1 (es) Metodo de producir derivados de tiazolidina
GR3005315T3 (ro)
IE42216L (en) Benzomorphane derivatives
JPS5412372A (en) Thiazolidine derivative and its preparation
IE41528L (en) Furfuryl-benzomorphane derivatives.
GB1489609A (en) 1-substituted 1h-tetrazole-5-thiols and the preparation thereof
IE780899L (en) Azetidinopyrrole derivatives
IE41440L (en) Thiatetracyclines
IE42979L (en) Pyrazinyl piperazine derivatives
IE40335B1 (en) Pyrazole derivatives, process for their preparation and their use as medicaments
GB1355147A (en) Oxoprostanoic acid derivatives
IE44339L (en) Piperazine derivatives.
SE8003351L (sv) Forfarande for framstellning av heterocykliska foreningar med terapeutisk verkan
IE780279L (en) Imidazole derivatives
NO865181L (no) Fremgangsmaate for fremstilling av gamma-thiobutyrolacton-derivater.
GB1498535A (en) Heterocyclic compounds
IE39770L (en) Thiazole derivatives
SE436137B (sv) Forfarande for framstellning av proteasinhibitorer, benemnda procidiner, genom odling av den nya stammen atcc 31233, tillhorande slektet actinomadura
ES8300775A1 (es) "procedimiento para la fabricacion de un n-bencenosulfonil derivado de la cefamicina c".
IE792287L (en) Urethane derivatives
JPS52100473A (en) Novel azimidebenzamide derivative and its production
JPS54106491A (en) Cephalosporin analog or its salt, their preparation, and prophylactics and remedies for microbisms consisting mainly of them
GB1473981A (en) Hydrazino-cephalosporanic acid derivatives
JPS574981A (en) Novel amino glucoside

Legal Events

Date Code Title Description
1K4A Payment of annual fees